As the United States transitions from a government-funded COVID-19 vaccination program to commercial offerings, over 25 million adults may have limited access to no-cost COVID-19 vaccines.
To address this significant vaccine-equity issue, the U.S. CDC's Advisory Committee on Immunization Practices (ACIP) today presented the temporary Bridge Access Program.
Read More
